Camp4 Therapeutics Corporation (CAMP)
NASDAQ: CAMP · Real-Time Price · USD
4.420
+0.140 (3.27%)
Jul 7, 2026, 1:12 PM EDT - Market open
Camp4 Therapeutics Market Cap
Camp4 Therapeutics has a market cap or net worth of $229.51 million as of July 7, 2026. Its market cap has increased by 713.31% in one year.
Market Cap
229.51M
Enterprise Value
130.61M
1-Year Change
713.31%
Ranking
Category
Stock Price
$4.42
Market Cap Chart
Since the IPO on October 11, 2024, Camp4 Therapeutics's market cap has increased from $208.55M to $229.51M, an increase of 10.05%. That is a compound annual growth rate of 5.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 7, 2026 | 229.51M | -27.83% |
| Dec 31, 2025 | 318.03M | 202.65% |
| Dec 31, 2024 | 105.08M | -49.61% |
| Oct 11, 2024 | 208.55M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cellectis | 236.86M |
| Atrium Therapeutics | 233.49M |
| Nkarta | 230.38M |
| Alector | 228.71M |
| Voyager Therapeutics | 228.39M |
| Protara Therapeutics | 228.19M |
| Whitehawk Therapeutics | 225.35M |
| NervGen Pharma | 225.15M |